One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Real-world Positioning and Effectiveness of First- and Second-Line Biological Therapy in Inflammatory Bowel DiseasesÂ
Joana Revés, Joana Torres
doi : 10.1093/ecco-jcc/jjae001
Volume 18, Issue 6, June 2024
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource
doi : 10.1093/ecco-jcc/jjad203
Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study
doi : 10.1093/ecco-jcc/jjad201
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn’s Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies
doi : 10.1093/ecco-jcc/jjad206
Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study
doi : 10.1093/ecco-jcc/jjae008
Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic Review
doi : 10.1093/ecco-jcc/jjad214
Beyond the Gut: A Systematic Review and Meta-analysis of Advanced Therapies for Inflammatory Bowel Disease-associated Extraintestinal Manifestations
doi : 10.1093/ecco-jcc/jjae002
Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn’s Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial
doi : 10.1093/ecco-jcc/jjae003
Baseline Data and Measurement Instruments Reported in Observational Studies in Inflammatory Bowel Disease: Results from a Systematic Review
doi : 10.1093/ecco-jcc/jjae004
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial
doi : 10.1093/ecco-jcc/jjae007
Epigenetic and Metabolic Reprogramming of Fibroblasts in Crohn’s Disease Strictures Reveals Histone Deacetylases as Therapeutic Targets
doi : 10.1093/ecco-jcc/jjad209
D-alanine Inhibits Murine Intestinal Inflammation by Suppressing IL-12 and IL-23 Production in Macrophages
doi : 10.1093/ecco-jcc/jjad217
The Impact of Dietary Interventions on the Microbiota in Inflammatory Bowel Disease: A Systematic Review
doi : 10.1093/ecco-jcc/jjad204
Outcomes and Endpoints of Postoperative Recurrence in Crohn’s Disease: Systematic Review and Consensus Conference
doi : 10.1093/ecco-jcc/jjad205
Diagnostic Accuracy of Intestinal Ultrasound in the Detection of Intra-Abdominal Complications in Crohn’s Disease: A Systematic Review and Meta-Analysis
doi : 10.1093/ecco-jcc/jjad215
Tofacitinib in Chronic Inflammatory Pouch Diseases: A Systematic Review
doi : 10.1093/ecco-jcc/jjad207
Correction to: Female and Male Fertility after Colectomy and Reconstructive Surgery in Inflammatory Bowel Disease: A National Cohort Study from Sweden
doi : 10.1093/ecco-jcc/jjad210
Erratum to: Ustekinumab as Induction and Maintenance Therapy in Patients with Inflammatory Bowel Disease and Type II Autoimmune Pancreatitis: Report of Two Cases
doi : 10.1093/ecco-jcc/jjae005
